News

In The News The House passed the Build Back Better reconciliation bill on Friday, which includes authorization for the government to negotiate lower drug prices. ADVI Health’s Lindsay Bealor Greenleaf shared insights on the measure with Pharmacy Times
In The News ADVI’s Lindsay Bealor Greenleaf shared her insights with AISHealth on a majorly overlooked aspect of the Build Back Better Act
In The News ADVI’s Lindsay Bealor Greenleaf talked to Pharmacy Times about the role of the federal government in drug pricing & how the Build Back Better Act would impact it moving forward
In The News Caitlin Sheetz, Director and Head of Analytics at ADVI, spoke with Kaiser Health News’ Julie Appleby about the Trump administration’s now-in-effect hospital price transparency rule, offering consumers advice on how to find hospitals’ shoppable services.
In The News ADVI’s Head of Analytics, Caitlin Sheetz, spoke with Robert King from FierceHealthcare about CMS’ approach to hospitals price transparency:
In The News Our VP, Lindsay Bealor Greenleaf, talks with Sarah Karlin-Smith about HHS’s OIG opinion on Novartis’ CAR-T
In The News “Her experience on the Hill and in the White House have honed what already was a storied career in health services research.” ADVI CEO Marc Samuels told Pink Sheet about Liz Fowler, the new Director of CMMI
In The News ADVI Health Awarded Innovator License to Medicare, Medicaid, and Medicare Advantage Claims
In The News The Commercial Appeal examined our new report on hospital price transparency, which found that not all U.S. hospitals are publishing mandatory cost information in the same way